FDAnews Announces CDRH's New Accreditation Scheme for Conformity Assessment: Impacts on Your Future Testing Plans and FDA Submissions Webinar May 19, 2021
Thursday, May 13, 2021
Thinking of participating in CDRH's ASCA pilot? Find out the pros and cons by registering for this webinar today.
FALLS CHURCH, Va., May 5, 2021 /PRNewswire-PRWeb/ -- Ready to take advantage of the FDA's Center for Devices and Radiological Health's (CDRH) new Accreditation Scheme for Conformity Assessment (ASCA) pilot program?
There are definite benefits to devicemakers when they participate -- ASCA allows accredited testing laboratories to assess the conformance of a device with FDA-recognized standards.
After all, it was the FDA's goal when it launched the pilot in September 2020 to increase the consistency and predictability with which testing will meet recognized standards.
In this webinar, two members of King & Spalding's FDA and Life Sciences practice -- Elaine Tseng, a partner, and Quynh Hoang, a senior regulatory consultant and 24-year veteran of CDRH -- will give an overview of the ASCA pilot, show attendees how to conform to it and use it to their advantage, explaining:
-- Who may participate in the ASCA pilot
-- Pros and cons of participating
-- What participants can expect
-- Implications of the ASCA pilot moving forward
-- What information is made available on pilot participants
Understand the potential impact of the ASCA on your testing plans.
Interested in registering multiple sites?
Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally
to learn about our special multisite discount.
Webinar Details:
CDRH's New Accreditation Scheme for Conformity Assessment:
Impacts on Your Future Testing Plans and FDA Submissions
An FDAnews Webinar
Wednesday, May 19, 2021, 1:30 p.m.-3:00 p.m. EDT
https://wcg.swoogo.com/cdrh-new-accreditation-scheme-for-conformity-assessment
Tuition:
$287 per site
Easy Ways to Register:
Online: https://wcg.swoogo.com/cdrh-new-accreditation-scheme-for-conformity-assessment
By phone: 888.838.5578 or 703.538.7600
About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations
Media Contact
Michelle Butler, FDAnews, 703.538.7600, mbutler@wcgclinical.com
SOURCE FDAnews
|
|
|
|
|
 |
Asetek - Mandatory Notification of Trade | Jan 22, 2026
|
|
Tomorrowland Brings the Magic to Shanghai for a Spectacular First Indoor Edition in China | Jan 22, 2026
|
|
BC.GAME to Host "Stay Untamed" Night During Abu Dhabi's Packed Web3 Summit Week | Jan 22, 2026
|
|
Auburn University's Applied Research Institute Expands Advanced Manufacturing Capabilities with CF3D Enterprise Cell | Jan 22, 2026
|
|
California Divorce Mediation Center Unveils Modern Website Redesign | Jan 22, 2026
|
|
Rent Manager Earned Best Real Estate Software Product Award and Multiple Review Badges from G2 Platform | Jan 22, 2026
|
|
AMPERA ANNOUNCES LOCATION FOR GLOBAL HEADQUARTERS | Jan 22, 2026
|
|
Culture and tourism sectors thrive in Xiamen | Jan 22, 2026
|
|
Immutable Announces First Co-Founder-Hosted Live Webinar: How to Dominate Your Steam Launch | Jan 22, 2026
|
|
StackGen Named in Four Gartner® Hype Cycles(TM) for Platform Engineering, Infrastructure Strategy, Site Reliability Engineering, and I&O Automation in 2025 | Jan 22, 2026
|
|
|
